BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26524031)

  • 21. [Inhibitory effect of compound cantharides capsule on the proliferation of xenografts of human hepatocellular carcinoma HepG(2)215 in mice].
    Han JJ; Yu JM; Wu HY; Liu JB; Song B; Xue DW
    Zhonghua Zhong Liu Za Zhi; 2012 Nov; 34(11):821-5. PubMed ID: 23291129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of human diffuse large B-cell lymphoma growth by JC polyomavirus-like particles delivering a suicide gene.
    Chao CN; Huang YL; Lin MC; Fang CY; Shen CH; Chen PL; Wang M; Chang D; Tseng CE
    J Transl Med; 2015 Jan; 13():29. PubMed ID: 25623859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Potential mechanism and prognostic value of promoter methylation of PRDM1 gene in diffuse large B cell lymphoma].
    Zhang XY; Ma ZP; Cui WL; Chen R; Glinaer A; Miao N; Li XX
    Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):831-837. PubMed ID: 28056297
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of neferine on CCL5 and CCR5 expression in SCG of type 2 diabetic rats.
    Li G; Xu H; Zhu S; Xu W; Qin S; Liu S; Tu G; Peng H; Qiu S; Yu S; Zhu Q; Fan B; Zheng C; Li G; Liang S
    Brain Res Bull; 2013 Jan; 90():79-87. PubMed ID: 23063706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The biological and clinical impact of inhibition of NF-κB-initiated apoptosis in diffuse large B cell lymphoma (DLBCL).
    Bavi P; Uddin S; Bu R; Ahmed M; Abubaker J; Balde V; Qadri Z; Ajarim D; Al-Dayel F; Hussain AR; Al-Kuraya KS
    J Pathol; 2011 Jul; 224(3):355-66. PubMed ID: 21506127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The critical role of RasGRP4 in the growth of diffuse large B cell lymphoma.
    Zhu L; Xia C; Wu L; Zhang Y; Liu J; Chen Y; Liu J; Xiao Y; Nie K; Huang L; Qu N; Yu H
    Cell Commun Signal; 2019 Aug; 17(1):92. PubMed ID: 31409422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor-derived CCL5 does not contribute to breast cancer progression.
    Jayasinghe MM; Golden JM; Nair P; O'Donnell CM; Werner MT; Kurt RA
    Breast Cancer Res Treat; 2008 Oct; 111(3):511-21. PubMed ID: 17978871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-9 promotes cell survival and drug resistance in diffuse large B-cell lymphoma.
    Lv X; Feng L; Ge X; Lu K; Wang X
    J Exp Clin Cancer Res; 2016 Jul; 35(1):106. PubMed ID: 27364124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The microenvironment of DLBCL is characterized by noncanonical macrophages recruited by tumor-derived CCL5.
    Manfroi B; De Grandis M; Moreaux J; Tabruyn S; Mayol JF; Quintero M; Righini C; Sturm N; Aurrand-Lions M; Huard B
    Blood Adv; 2021 Nov; 5(21):4338-4351. PubMed ID: 34516642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of down-regulation of CC chemokine ligand 5 (CCL5) on proliferation of human breast cancer cells in vitro].
    Kuang JX; Wang WX; Sun SR; Wang WR; Yao XL
    Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):174-7. PubMed ID: 21575514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Klotho, an anti-aging gene, acts as a tumor suppressor and inhibitor of IGF-1R signaling in diffuse large B cell lymphoma.
    Zhou X; Fang X; Jiang Y; Geng L; Li X; Li Y; Lu K; Li P; Lv X; Wang X
    J Hematol Oncol; 2017 Feb; 10(1):37. PubMed ID: 28153033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphoma.
    Zhang M; Xu-Monette ZY; Li L; Manyam GC; Visco C; Tzankov A; Wang J; Montes-Moreno S; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; Han van Krieken J; Huh J; Ponzoni M; Ferreri AJ; Møller MB; Parsons BM; Winter JN; Piris MA; Medeiros LJ; Pham LV; Young KH
    Aging (Albany NY); 2016 Dec; 8(12):3321-3340. PubMed ID: 27941215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fbw7 regulates apoptosis in activated B-cell like diffuse large B-cell lymphoma by targeting Stat3 for ubiquitylation and degradation.
    Yao S; Xu F; Chen Y; Ge Y; Zhang F; Huang H; Li L; Lin D; Luo X; Xu J; Luo D; Zhu X; Liu Y
    J Exp Clin Cancer Res; 2017 Jan; 36(1):10. PubMed ID: 28069035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.
    Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH
    Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [B cells from streptozotocin-induced mouse diabetic model inhibit insulin secretion of MIN-6 cells and promote production of insulin autoantibody].
    Qin M; Xu Q; Wang P; Tang Q; Sun J; Wei W; Huang B
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Dec; 31(12):1593-6. PubMed ID: 26648288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor activity of fucoidan against diffuse large B cell lymphoma in vitro and in vivo.
    Yang G; Zhang Q; Kong Y; Xie B; Gao M; Tao Y; Xu H; Zhan F; Dai B; Shi J; Wu X
    Acta Biochim Biophys Sin (Shanghai); 2015 Nov; 47(11):925-31. PubMed ID: 26358321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of topical external administration of recombinant human epidermal growth factor on expression of epidermal growth factor receptor and its mRNA in scald wound of diabetes mellitus rat].
    Zong S; Liang Z; Ou B
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2010 Feb; 24(2):150-5. PubMed ID: 20187444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary central nervous system diffuse large B-cell lymphoma shows an activated B-cell-like phenotype with co-expression of C-MYC, BCL-2, and BCL-6.
    Li X; Huang Y; Bi C; Yuan J; He H; Zhang H; Yu Q; Fu K; Li D
    Pathol Res Pract; 2017 Jun; 213(6):659-665. PubMed ID: 28552541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic strategy with artificially-designed i-lncRNA targeting multiple oncogenic microRNAs exhibits effective antitumor activity in diffuse large B-cell lymphoma.
    Su Y; Sun B; Lin X; Zhao X; Ji W; He M; Qian H; Song X; Yang J; Wang J; Chen J
    Oncotarget; 2016 Aug; 7(31):49143-49155. PubMed ID: 27172795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A dual role for tumor-derived chemokine RANTES (CCL5).
    Adler EP; Lemken CA; Katchen NS; Kurt RA
    Immunol Lett; 2003 Dec; 90(2-3):187-94. PubMed ID: 14687724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.